Sareum’s small molecule drug discovery expertise builds value by developing drug candidates, focused on cancer and autoimmune disease, for licencing to pharmaceutical and biotechnology companies.
Find out more about us
16 August 2019
08 August 2019
30 July 2019
28 June 2019
Find out more
Sareum actively seeks collaboration partners for its research programmes.
Sareum has an innovative pipeline of drug development candidates.
BioTrinity, April 2019 (Slides)Proactive Investors, March 2019 (Video)
Share price dataRegulatory News Service (RNS)
Sareum LimitedUnit 2A, Langford ArchLondon Road, PampisfordCambridge CB22 3FXUnited Kingdom
tel: +44 (0) 1223 497700fax: +44 (0) 1223 497701
Yearly Results 2018 Notice of AGM 2018
Annual Report 2018 AGM Votes 2018